FNY Investment Advisers’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-383
Closed -$114K 660
2024
Q3
$123K Buy
383
+155
+68% +$50.7K 0.06% 211
2024
Q2
$71K Sell
228
-117
-34% -$34.4K 0.05% 213
2024
Q1
$98 Buy
+345
New +$101K 0.06% 182
2019
Q4
Sell
-41
Closed -$7K 805
2019
Q3
$7K Buy
+41
New +$7.87K ﹤0.01% 613
2018
Q4
Sell
-386
Closed -$80K 670
2018
Q3
$80K Buy
+386
New +$76.1K 0.02% 298

Other funds holding AMGN

FNY Investment Advisers's AMGN Position: Q4 2024 in Review

FNY Investment Advisers sold out of Amgen (AMGN) in Q4 2024, closing a stake of 383 shares — an estimated $114K sold.

FNY Investment Advisers first reported a position in AMGN in Q3 2018 and held it in 5 quarters. The position peaked at $123K in Q3 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • FNY Investment Advisers reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • FNY Investment Advisers sold 383 Amgen shares in Q4 2024, an estimated $114K.
  • FNY Investment Advisers first reported a position in Amgen in Q3 2018 and held it in 5 quarters.
  • FNY Investment Advisers's Amgen position peaked at $123K in Q3 2024.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on FNY Investment Advisers's 13F filing for Q4 2024, filed 13 Jan 2025.